Literature DB >> 25939207

Progress in the PROSPECT trial: precision treatment for rectal cancer?

Martin R Weiser, Alessandro Fichera, Deborah Schrag, Judy C Boughey, Y Nancy You.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 25939207

Source DB:  PubMed          Journal:  Bull Am Coll Surg        ISSN： 0002-8045


× No keyword cloud information.
  14 in total

Review 1.  How Should Imaging Direct/Orient Management of Rectal Cancer?

Authors:  Jemma Bhoday; Svetlana Balyasnikova; Anita Wale; Gina Brown
Journal:  Clin Colon Rectal Surg       Date:  2017-11-27

Review 2.  Recent advances in multidisciplinary approach for rectal cancer.

Authors:  Eiji Oki; Koji Ando; Yuta Kasagi; Yoko Zaitsu; Masahiko Sugiyama; Yuichiro Nakashima; Hideto Sonoda; Kippei Ohgaki; Hiroshi Saeki; Yoshihiko Maehara
Journal:  Int J Clin Oncol       Date:  2015-06-23       Impact factor: 3.402

3.  Facility Variation in Local Staging of Rectal Adenocarcinoma and its Contribution to Underutilization of Neoadjuvant Therapy.

Authors:  Douglas S Swords; Benjamin S Brooke; David E Skarda; Gregory J Stoddard; H Tae Kim; William T Sause; Courtney L Scaife
Journal:  J Gastrointest Surg       Date:  2018-11-12       Impact factor: 3.452

4.  Use of comprehensive genomic profiling to direct point-of-care management of patients with gynecologic cancers.

Authors:  Lorna Rodriguez-Rodriguez; Kim M Hirshfield; Veronica Rojas; Robert S DiPaola; Darlene Gibbon; Mira Hellmann; Sara Isani; Aliza Leiser; Gregory M Riedlinger; Allison Wagreich; Siraj M Ali; Julia A Elvin; Vincent A Miller; Shridar Ganesan
Journal:  Gynecol Oncol       Date:  2016-04       Impact factor: 5.482

5.  Response to chemoradiotherapy and lymph node involvement in locally advanced rectal cancer.

Authors:  Luis J García-Flórez; Guillermo Gómez-Álvarez; Ana M Frunza; Luis Barneo-Serra; Manuel F Fresno-Forcelledo
Journal:  World J Gastrointest Surg       Date:  2015-09-27

6.  Surgeon-Level Variation in Utilization of Local Staging and Neoadjuvant Therapy for Stage II-III Rectal Adenocarcinoma.

Authors:  Douglas S Swords; David E Skarda; William T Sause; Ute Gawlick; George M Cannon; Mark A Lewis; Courtney L Scaife; Jesse A Gygi; H Tae Kim
Journal:  J Gastrointest Surg       Date:  2019-01-31       Impact factor: 3.452

7.  Pelvic MRI after induction chemotherapy and before long-course chemoradiation therapy for rectal cancer: What are the imaging findings?

Authors:  Marc J Gollub; Ivana Blazic; David D B Bates; Naomi Campbell; Andrea Knezevic; Mithat Gonen; Patricio Lynn; Martin R Weiser; Julio Garcia-Aguilar; Andreas M Hötker; Andrea Cercek; Leonard Saltz
Journal:  Eur Radiol       Date:  2018-10-02       Impact factor: 5.315

Review 8.  The rise of genomic profiling in ovarian cancer.

Authors:  Rebecca A Previs; Anil K Sood; Gordon B Mills; Shannon N Westin
Journal:  Expert Rev Mol Diagn       Date:  2016-12       Impact factor: 5.225

9.  The role of neoadjuvant radiotherapy for locally-advanced rectal cancer with resectable synchronous metastasis.

Authors:  Croix C Fossum; Jasim Y Alabbad; Lindsay B Romak; Christopher L Hallemeier; Michael G Haddock; Marianne Huebner; Eric J Dozois; David W Larson
Journal:  J Gastrointest Oncol       Date:  2017-08

Review 10.  Endoscopic and MRI response evaluation following neoadjuvant treatment for rectal cancer: a pictorial review with matched MRI, endoscopic, and pathologic examples.

Authors:  Seth I Felder; Sebastian Feuerlein; Arthur Parsee; Iman Imanirad; Julian Sanchez; Sophie Dessureault; Richard Kim; Sarah Hoffe; Jessica Frakes; James Costello
Journal:  Abdom Radiol (NY)       Date:  2020-10-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.